BACKGROUND: The well-described biologic and epidemiologic associations of syphilis and HIV are particularly relevant to the military, as service members are young and at risk for sexually transmitted infections. We therefore used the results of serial serologic testing to determine the prevalence, incidence, and risk factors for incident syphilis in a cohort of HIV-infected Department of Defense beneficiaries. METHODS: Participants with a positive nontreponemal test at HIV diagnosis that was confirmed on treponemal testing were categorized as prevalent cases, and participants with an initial negative nontreponemal test who subsequently developed a confirmed positive nontreponemal test were categorized as incident cases. RESULTS: At HIV diagnosis, the prevalence of syphilis was 5.8% (n = 202). A total of 4239 participants contributed 27,192 person-years (PY) to the incidence analysis and 347 (8%) developed syphilis (rate, 1.3/100 PY; [1.1, 1.4]). Syphilis incidence was highest during the calendar years 2006 to 2009 (2.5/100 PY; [2.0, 2.9]). In multivariate analyses, younger age (per 10 year increase hazard ratio [HR], 0.8; [0.8-0.9]), male gender (HR, 5.6; [2.3-13.7]), non-European-American ethnicity (African-American HR, 3.2; [2.5-4.2]; Hispanic HR, 1.9; [1.2-3.0]), and history of hepatitis B (HR, 1.5; [1.2-1.9]) or gonorrhea (HR, 1.4; [1.1-1.8]) were associated with syphilis. CONCLUSIONS: The significant burden of disease both at and after HIV diagnosis, observed in this cohort, suggests that the cost-effectiveness of extending syphilis screening to at-risk military members should be assessed. In addition, HIV-infected persons continue to acquire syphilis, emphasizing the continued importance of prevention for positive programs.
BACKGROUND: The well-described biologic and epidemiologic associations of syphilis and HIV are particularly relevant to the military, as service members are young and at risk for sexually transmitted infections. We therefore used the results of serial serologic testing to determine the prevalence, incidence, and risk factors for incident syphilis in a cohort of HIV-infected Department of Defense beneficiaries. METHODS:Participants with a positive nontreponemal test at HIV diagnosis that was confirmed on treponemal testing were categorized as prevalent cases, and participants with an initial negative nontreponemal test who subsequently developed a confirmed positive nontreponemal test were categorized as incident cases. RESULTS: At HIV diagnosis, the prevalence of syphilis was 5.8% (n = 202). A total of 4239 participants contributed 27,192 person-years (PY) to the incidence analysis and 347 (8%) developed syphilis (rate, 1.3/100 PY; [1.1, 1.4]). Syphilis incidence was highest during the calendar years 2006 to 2009 (2.5/100 PY; [2.0, 2.9]). In multivariate analyses, younger age (per 10 year increase hazard ratio [HR], 0.8; [0.8-0.9]), male gender (HR, 5.6; [2.3-13.7]), non-European-American ethnicity (African-American HR, 3.2; [2.5-4.2]; Hispanic HR, 1.9; [1.2-3.0]), and history of hepatitis B (HR, 1.5; [1.2-1.9]) or gonorrhea (HR, 1.4; [1.1-1.8]) were associated with syphilis. CONCLUSIONS: The significant burden of disease both at and after HIV diagnosis, observed in this cohort, suggests that the cost-effectiveness of extending syphilis screening to at-risk military members should be assessed. In addition, HIV-infectedpersons continue to acquire syphilis, emphasizing the continued importance of prevention for positive programs.
Authors: Cynthia W Baffi; Inmaculada Aban; James H Willig; Mayank Agrawal; Michael J Mugavero; Laura H Bachmann Journal: AIDS Patient Care STDS Date: 2010-01 Impact factor: 5.078
Authors: David E Ostrow; Kelly J Fox; Joan S Chmiel; Anthony Silvestre; Barbara R Visscher; Peter A Vanable; Lisa P Jacobson; Steffanie A Strathdee Journal: AIDS Date: 2002-03-29 Impact factor: 4.177
Authors: Kate Buchacz; Jeffrey D Klausner; Peter R Kerndt; R Luke Shouse; Ida Onorato; Peter D McElroy; Joseph Schwendemann; Pradnya B Tambe; Michelle Allen; Frank Coye; Charlotte k Kent; Mahin N Park; Kellie Hawkins; Erika Samoff; John T Brooks Journal: J Acquir Immune Defic Syndr Date: 2008-02-01 Impact factor: 3.731
Authors: Amy C Weintrob; Greg A Grandits; Brian K Agan; Anuradha Ganesan; Michael L Landrum; Nancy F Crum-Cianflone; Erica N Johnson; Claudia E Ordóñez; Glenn W Wortmann; Vincent C Marconi Journal: J Acquir Immune Defic Syndr Date: 2009-12 Impact factor: 3.731
Authors: Judith Branger; Jan T M van der Meer; Ruud J van Ketel; Suzanne Jurriaans; Jan M Prins Journal: Sex Transm Dis Date: 2009-02 Impact factor: 2.830
Authors: Brian K Agan; Anuradha Ganesan; Morgan Byrne; Robert Deiss; Christina Schofield; Ryan C Maves; Jason Okulicz; Xiuping Chu; Thomas O'Bryan; Tahaniyat Lalani; Karl Kronmann; Tomas Ferguson; Merlin L Robb; Timothy J Whitman; Timothy H Burgess; Nelson Michael; Edmund Tramont Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Sarah E Wiehe; Marc B Rosenman; Matthew C Aalsma; Michael L Scanlon; J Dennis Fortenberry Journal: Am J Public Health Date: 2015-10-15 Impact factor: 9.308
Authors: David W Purcell; Yoko Mizuno; Dawn K Smith; Kristina Grabbe; Cari Courtenay-Quick; Hank Tomlinson; Jonathan Mermin Journal: Arch Sex Behav Date: 2014-01
Authors: Jin Young Ahn; David Boettiger; Sasisopin Kiertiburanakul; Tuti Parwati Merati; Bui Vu Huy; Wing Wai Wong; Rossana Ditangco; Man Po Lee; Shinichi Oka; Nicolas Durier; Jun Yong Choi Journal: J Int AIDS Soc Date: 2016-10-21 Impact factor: 5.396
Authors: Ann N Burchell; Vanessa G Allen; Sandra L Gardner; Veronika Moravan; Darrell H S Tan; Ramandip Grewal; Janet Raboud; Ahmed M Bayoumi; Rupert Kaul; Tony Mazzulli; Frank McGee; Sean B Rourke Journal: BMC Infect Dis Date: 2015-08-20 Impact factor: 3.090